Skip to main content
P

ProBiotix Health Plc — Investor Relations & Filings

Ticker · PBX ISIN · GB00BLNBFR86 LEI · 98450048683CF0388C30 Aquis Stock Exchange Manufacturing
Open in API
Filings indexed 63 across all filing types
Latest filing 2026-03-30 Earnings Release
Country GB United Kingdom
Listing Aquis Stock Exchange PBX

About ProBiotix Health Plc

https://www.probiotixhealth.com/

ProBiotix Health Plc is a life sciences company that develops and supplies scientifically validated, probiotic-based microbiome solutions. The company specializes in formulations for cardiometabolic health, targeting conditions related to cholesterol, blood pressure, and vascular health, as well as healthy aging. Its core technology is LPLDL®, a patented and trademarked Lactobacillus plantarum strain demonstrated in human clinical trials to be effective in managing key cardiometabolic markers. ProBiotix Health offers its technology as both a raw ingredient and in finished product formulations, such as the YourBiotix and CholBiome® lines, for the global dietary supplement market. The company's approach is rooted in extensive research and development, conducted in collaboration with universities and scientific advisors to ensure product efficacy and safety.

Recent filings

Filing Released Lang Actions
Final Results and Investor Presentation
Earnings Release Classification · 1% confidence The document is a UK RNS announcement titled “Final Results and Investor Presentation” containing audited results for the year ended 31 December 2025, key financial highlights, management commentary, and a notice of an investor presentation. It is not the full statutory Annual Report itself, but rather an earnings release announcing annual results and inviting investors to a presentation. This matches the definition for an Earnings Release (ER). FY 2025
2026-03-30 English
Notice of Results and Investor Presentation
Report Publication Announcement Classification · 1% confidence The document is a short announcement (under 5,000 characters) from ProBiotix Health PLC regarding the upcoming release of their audited results and an invitation to an investor presentation. It does not contain the actual financial results, but rather serves as a notification of when those results will be published. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2026-03-16 English
PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is a formal notification of a share acquisition by a Person Discharging Managerial Responsibilities (PDMR). It explicitly includes the 'Notification and public disclosure of transactions by persons discharging managerial responsibilities' table, which is the standard format for reporting insider dealings. This aligns perfectly with the 'Director's Dealing' (DIRS) category.
2026-02-17 English
Statement re Share Price Movement
Regulatory Filings Classification · 1% confidence The document is a short announcement issued via RNS (Regulatory News Service) regarding a company's share price movement. It clarifies that there are no fundamental commercial or operational reasons for the recent share price decline and reaffirms trading momentum. As it is a general regulatory announcement that does not fit into specific categories like financial reports, dividends, or director dealings, it falls under the RNS (Regulatory Filings) category.
2026-02-16 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a TR-1 form, which is the standard regulatory notification for major shareholding changes in the UK. It explicitly details the crossing of a voting rights threshold (from 6.6% to 4.9976%) by Seneca Partners Limited in ProBiotix Health Plc. This fits the definition of a Major Shareholding Notification (MRQ).
2026-02-05 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is a formal notification of a share acquisition by a company director (Adam Reynolds, Chairman of ProBiotix Health plc). It includes the standard regulatory disclosure table for transactions by persons discharging managerial responsibilities (PDMR), which is a classic 'Director's Dealing' filing. It is not a report publication announcement, but rather the primary disclosure of the transaction itself.
2026-02-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.